NCT01355588 - Tolerability, Safety and Pharmacokinetics of Four Formulations of Ketorolac Tromethamine in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

March 31, 2006

Conditions

Healthy Volunteers

Interventions

DRUG

Ketorolac Tromethamine

30 mg Ketorolac Tromethamine intranasal (IN)

DRUG

Ketorolac Tromethamine with 4% Lidocaine hydrochloride (HCl)

30 mg Ketorolac Tromethamine with 4% Lidocaine HCl IN

DRUG

Ketorolac Tromethamine with 5% Lidocaine HCl

30 mg Ketorolac Tromethamine with 5% Lidocaine HCl IN

DRUG

30 mg Ketorolac Tromethamine with 6% Lidocaine HCl

30 mg Ketorolac Tromethamine with 6% Lidocaine HCl IN

Trial Locations (1)

Medeval Ltd, Manchester